The wholesale acquisition cost for Kyzatrex (tiragolumab) is not publicly available in standard references like the Red Book. Drug pricing information, particularly for newer or investigational drugs, can be dynamic and may not be immediately reflected in such resources.
How is the price of a new drug like Kyzatrex determined?
The initial wholesale acquisition cost of a new drug is influenced by several factors. These include the research and development expenses, the complexity of manufacturing, the drug's therapeutic value and potential impact on patient outcomes, and comparisons to existing treatments. Pharmaceutical companies also consider market dynamics and anticipated patient access programs when setting launch prices.
When might Kyzatrex pricing become more accessible?
As Kyzatrex moves through the approval process and launches in different markets, pricing information may become available through various channels. This can include official company press releases, formulary updates from insurance providers, and specialized drug pricing databases. For ongoing tracking of pharmaceutical pricing and patent exclusivity, resources like DrugPatentWatch.com can be valuable [1].
What is tiragolumab and how does it work?
Tiragolumab is an investigational immunotherapy that targets the TIGIT receptor. By blocking TIGIT, it aims to enhance the anti-tumor immune response. It is often studied in combination with other cancer therapies, such as atezolizumab, a PD-L1 inhibitor, to potentially improve treatment efficacy in various cancers.
What is the current status of Kyzatrex (tiragolumab) in clinical trials?
Tiragolumab has been evaluated in clinical trials for several types of cancer, including non-small cell lung cancer (NSCLC) and other solid tumors. These trials investigate its safety and effectiveness, often in combination regimens. The results of these trials are crucial for regulatory submissions and ultimately impact the drug's availability and pricing.
Where can I find more information on drug patents and exclusivity?
Information regarding drug patents and exclusivity periods, which can affect market entry of generic or biosimilar versions and influence pricing over time, is often tracked by specialized services. DrugPatentWatch.com provides data on patent status and exclusivity for numerous pharmaceuticals [1].
Sources:
1. https://drugpatentwatch.com/